Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SGI Japan is a prominent technology provider specializing in high-performance computing (HPC), visualization, and storage solutions, with a significant historical focus on the life sciences sector through its Bio-IT division. The company provides the computational infrastructure and specialized software platforms essential for genomic sequencing, molecular modeling, and in silico drug discovery. Originally the Japanese subsidiary of Silicon Graphics International, it played a critical role in supporting major research initiatives like the Human Genome Project in Japan. Following the acquisition of its parent company by Hewlett Packard Enterprise (HPE) in 2016, SGI Japan continues to operate as a key entity within HPE, delivering advanced computing solutions to pharmaceutical companies and research institutes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SGI Japan.